Paraneoplastic cerebellar degeneration in ovarian carcinoma: case report with review of immune modulation.

Authors/Editors

Research Areas

Publication Details

Output type: Journal article

Author list: Bradley, Dottino, Rahaman

Publisher: BMJ Publishing Group

Publication year: 2008

Volume number: 18

Issue number: 6

Start page: 1364

End page: 7

Number of pages: -1356

ISSN: 1048-891X

eISSN: 1525-1438

Languages: English-Great Britain (EN-GB)

Unpaywall Data

Open access status: closed

Abstract

Paraneoplastic cerebellar degeneration (PCD) is a rare nonmetastatic complication of a carcinoma. It is typically mediated by antibodies generated against tumor antigens. These antigens are the same proteins as expressed on Purkinje cells within the cerebellum; immune activation in the central nervous system (CNS) results in the syndrome. A 56-year-old woman with stage IIIC serous ovarian carcinoma diagnosed 3 years prior developed progressive limb ataxia. Serum anti-Yo antibodies were positive, confirming the diagnosis of PCD. Treatment with plasmaphoresis, intravenous immune globulin, and immune modulation with corticosteroids and tacrolimus was unsuccessful. Although the syndrome can be debilitating and treatment options are limited, it may also be an example of a successful host immune response in certain cases.

Keywords

No matching items found.

Documents